Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
57,673,548
-
Share change
-
+775,430
-
Total reported value
-
$1,393,690,562
-
Put/Call ratio
-
37%
-
Price per share
-
$24.17
-
Number of holders
-
160
-
Value change
-
+$38,775,758
-
Number of buys
-
91
-
Number of sells
-
79
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q4 2019
As of 31 Dec 2019,
AERIE PHARMACEUTICALS INC - COM (AERI) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,673,548 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Partner Fund Management, L.P., Foresite Capital Management III, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), LEVIN CAPITAL STRATEGIES, L.P., Foresite Capital Management II, LLC, Foresite Capital Management IV, LLC, and Bank of New York Mellon Corp.
This page lists
160
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.